Oxular Limited
undisclosed
Oxular is an England-based biotechnology company that discovers and develops novel drugs for the treatment of retinal diseases.
-
2seventy Bio’s Preclinical and Clinical Stage Cell Therapy Pipeline
$5M
-
Decibel Therapeutics, Inc.
$109M
Decibel Therapeutics is a Massachusetts-based biotechnology company that researches and develops drugs for the treatment of ear, nose, and throat diseases.
Checkmate Pharmaceuticals, Inc.
$250M
Checkmate Pharmaceuticals is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.